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Abstract: Patients with severe limbal damage and limbal stem cell deficiency are a therapeutic chal-
lenge. We evaluated four decellularization protocols applied to the full-thickness and half-thickness 
porcine limbus, and we used two cell types to recellularize the decellularized limbi. The results 
demonstrated that all protocols achieved efficient decellularization. However, the method that best 
preserved the transparency and composition of the limbus extracellular matrix was the use of 0.1% 
SDS applied to the half-thickness limbus. Recellularization with the limbal epithelial cell line SIRC 
and human adipose-derived mesenchymal stem cells (hADSCs) was able to generate a stratified 
epithelium able to express the limbal markers p63, pancytokeratin, and crystallin Z from day 7 in 
the case of SIRC and after 14–21 days of induction when hADSCs were used. Laminin and collagen 
IV expression was detected at the basal lamina of both cell types at days 14 and 21 of follow-up. 
Compared with control native limbi, tissues recellularized with SIRC showed adequate picrosirius 
red and alcian blue staining intensity, whereas limbi containing hADSCs showed normal collagen 
staining intensity. These preliminary results suggested that the limbal substitutes generated in this 
work share important similarities with the native limbus and could be potentially useful in the fu-
ture. 
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1. Introduction 
Numerous diseases, including trauma, infections, congenital malformations, degen-
eration, and other conditions, may affect the transparency of the human cornea and cause 
blindness [1]. Cornea transplantation or keratoplasty is the gold-standard treatment for 
severe corneal diseases. However, keratoplasty is subjected to donor shortage [2], and is 
contraindicated in patients with severe limbal damage and limbal stem cell deficiency 
(LSCD) [3]. Patients affected by severe LSCD typically show corneal conjunctivalization 
and neovascularization, and the management of this condition is challenging [4]. 
In cases with unilateral disease, LSCD can be treated by transplanting autologous 
limbal tissue from a healthy eye to a damaged eye [5]. Autologous grafts are free from the 
risk of immune rejection, but are not available in bilateral cases and can potentially com-
promise the healthy donor eye, resulting in LSCD [6]. If an autologous transplant is not 
available, patients can be treated with allogeneic limbal grafts obtained from cadaveric or 
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living donors [5,6]. Allogeneic grafts are also subjected to important concerns, such as the 
risk of immune rejection [5] and graft survival [7]. The lack of a fully safe and efficient 
treatment makes necessary the search of therapeutic alternatives. 
In this regard, the development of cell culture methods allowing cell isolation and 
expansion is a major advance in the treatment of LSCD [6]. Using small limbal tissue bi-
opsies, current technology allows the generation of limbal stem cell populations that can 
be implanted in patients with LSCD [8]. Cultured limbal stem cells can be grafted as iso-
lated cells or by using different types of carriers and biomaterials such as the human am-
niotic membrane, fibrin, collagen, or synthetic biopolymers [9–11]. Alternative ap-
proaches such as the use of cultured oral mucosa keratinocytes have also been proposed 
for LSCD treatment [12]. Although promising, the clinical usefulness of most of these 
treatments should still be demonstrated. 
Development of novel tissue engineering technologies allowed the design and con-
struction of human organs that could replace damaged tissues [13]. Bioartificial tissues 
and organs can be generated using different methods and techniques. Two of the most 
promising methods are organ bioprinting [14,15] and scaffolds seeded with living cells 
[16,17]. On the one hand, bioprinting offers the possibility of fabricating complex con-
structs in which cells and biomaterials can be precisely deposited in a specific 3D struc-
ture. However, the fine structure of the human cornea and corneal limbus is very complex, 
and alternative approaches including the development of transparent bio-inks and com-
plex design protocols are in need to generate efficient limbal substitutes using bioprinting 
[14,15]. On the other hand, cell-seeded scaffolds have been extensively used in cornea tis-
sue engineering. In general, these methods make use of different types of biomaterials that 
can be prepared in the laboratory and subsequently seeded with living cells to generate a 
tissue substitute [16,17]. In the case of the cornea, several models of bioartificial corneas 
have been developed [18,19], and some of these models have been clinically evaluated 
[20–22]. Again, these techniques need to be significantly improved to allow the efficient 
reproduction of the delicate histoarchitecture of these tissues. 
One of the possible biofabrication alternatives used in cornea tissue engineering is 
xenograft decellularization. Decellularized natural tissues have the advantage of faith-
fully reproducing the native extracellular matrix (ECM) [23]. Although a number of works 
have focused on the development of decellularization protocols applied to the native cor-
nea, a fully efficient protocol able to preserve all ECM components is in need. In general, 
cornea xenografts can be decellularized by using chemical, physical, and biological meth-
ods [24]. Chemical protocols typically use different types of detergents such as sodium 
dodecyl sulfate (SDS) and Triton X-100, although ethylenediaminetetraacetic acid (EDTA) 
and hypertonic salts have also been used [25,26]. Physical methods are mostly based on 
freeze-thawing, osmotic pressure, and lyophilization, whereas biological protocols make 
use of enzymes such as trypsin, DNAse, and RNAse [24,27]. Although little clinical expe-
rience is available for the use of decellularized corneal xenografts, some preliminary clin-
ical trials have pointed out the biosafety and functionality of decellularized porcine cor-
neas in patients subjected to lamellar keratoplasty [26–29]. 
Regarding the corneal limbus, very few works focused on the optimization of decel-
lularization protocols specifically applied to this structure [30]. Allocated at the transition 
between the cornea and the sclera, the corneal limbus plays a key role in maintaining cor-
neal physiology, and its integrity and function are crucial for a normal corneal homeosta-
sis [31]. The three-dimensional structure of the limbus is very complex. The crypts of the 
limbus form specific pocket-like structures containing fibrovascular Vogt palisades that 
make up a fundamental micro-niche that houses and supports the limbal stem cells [32]. 
Unfortunately, the complex structure of the limbus is very difficult to reproduce in 
the laboratory using standard tissue engineering protocols. However, the use of decellu-
larization methods applied to the native limbi provides the specific morphology, struc-
ture, and protein composition of the corneal limbus [30], and offers the opportunity of 
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obtaining adequate limbal scaffolds for use in tissue engineering. In fact, some prelimi-
nary reports using SDS and NaCl decellularization protocols have described the efficient 
generation of limbal substitutes for use in regenerative medicine [11,28,30]. 
On the other hand, the search for alternative sources of extraocular cells free from the 
drawbacks and limitations associated with autologous limbal cells used in the treatment 
of LSCD is in need [33]. In this sense, a possible alternative is the use of human adipose-
derived mesenchymal stem cells (hADSCs), which have previously been shown to have 
differentiation potential to several types of corneal cells both ex vivo and in vivo [34]. 
In the present preliminary work, we evaluated several decellularization methods ap-
plied to the corneal limbus, and we generated recellularized limbal xenografts for future 
use in patients with limbal damage using two different cell sources. 
2. Materials and Methods 
2.1. Obtaining Decellularized Xenografts from Native Limbi 
The study protocol is schematically summarized in Figure 1. 
 
Figure 1. Schematic representation of the study protocol used in the present work. Fl: full-thickness limbus; HL: half-
thickness limbus; DL: decellularized limbus; RL: recellularized limbus. 
Fresh porcine eyes were obtained from a local slaughterhouse. On arrival to the la-
boratory, eyes were washed in PBS and the corneal limbus was carefully dissected using 
sterile scissors. Limbi contained 2–3 mm of sclera and 3–4 mm of cornea. Limbal rings 
were washed thoroughly in PBS with a mixture of antibiotics and antimycotics containing 
penicillin (1000 U/mL), streptomycin (1000 µg/mL), and amphotericin B (2.5 µg/mL) 
(Merck, Darmstadt, Germany), and the rest of the uvea, retina, iris, and ciliary body were 
removed with forceps. The rings were then sectioned into fragments approximately 1 cm 
in length consisting of the full-thickness limbus (FL). Parts of these fragments were then 
sectioned in two halves using a surgical blade to separate the anterior part of the limbus 
(the most superficial) from the posterior part (the most profound). Only the anterior half 
of the limbal fragments, corresponding to the half-thickness limbus (HL), was used. 
Both the FL and HL were subjected to four decellularization protocols combining 
several types of detergents (to dissolve cell membranes), distilled water (to induce osmotic 
cell lysis), NaCl (to promote cell swelling), and enzymes (to remove nucleic acids) (all 
these components were purchased from Merck): 
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 Protocol P1: Double-distilled water (ddH2O) for 24 h; 0.1% sodium dodecyl sulphate 
(SDS) (3 incubations of 24 h each). 
 Protocol P2: ddH2O for 24 h; 0.1% SDS for 24 h; wash in PBS; 1.5 M of NaCl (2 incu-
bations of 24 h each). 
 Protocol P3: ddH2O for 24 h; 0.1% SDS for 24 h; wash in PBS; 1% sodium deoxycholate 
(SDC) for 24 h; wash in PBS; 0.6% triton X-100 for 24 h; wash in PBS; 100 mg/L of 
DNAse and 20 mg/L of RNAse for 45 min. 
 Protocol P4: ddH2O for 24 h; 0.1% SDS for 24 h; wash in PBS; 1% sodium deoxycholate 
(SDC) for 24 h; wash in PBS; 0.6% triton X-100 for 24 h; wash in PBS; 100 mg/L of 
DNAse and 20 mg/L of RNAse for 45 min; wash in PBS; 0.05% Trypsin for 1 h. 
All detergents were dissolved in ddH2O. DNAse, RNAse, and trypsin were used at 
37 °C. All incubations were performed with agitation. After decellularization, decellular-
ized limbi (DLs) were washed 5 times in cold PBS (15 min each time) and stored at 4 °C. 
To assess transparency, DLs were placed on a black background and photographed. 
2.2. Evaluation of Decellularization Efficiency in DL 
To determine the efficiency of the four decellularization protocols applied to the cor-
neal limbus, DLs were analyzed using DNA quantification and 4′,6-diamidino2-phenyl-
indole (DAPI) staining. To quantify residual DNA in DLs, tissues were trimmed and pro-
cessed using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany). Isolated DNA was 
dissolved in water and quantified using a NanoDrop 2000 spectrophotometer (Thermo 
Fisher Scientific, Waltham, MA, USA). Results were then normalized with respect to the 
weight of dry tissue as previously reported [35,36], and 10 measurements were made per 
sample. To identify the presence of nuclei or nuclei remnants in DLs, each tissue was fixed 
in formalin and embedded in paraffin as described below, and tissue sections were ob-
tained using a microtome. Sections were dewaxed, rehydrated, stained with DAPI, co-
verslipped, and examined with a Nikon Eclipse i90 fluorescent microscope. 
2.3. Generation of Recellularized Limbal Substitutes by Tissue Engineering 
The DLs showing the best results were further recellularized with two types of cells: 
the limbal epithelial cell line SIRC (Statens Seruminstitut Rabbit Cornea) and primary cell 
cultures of mesenchymal stem cells (MSCs) derived from the adipose tissue (hADSCs). 
SIRC was purchased from ATCC (ref: CCL-60), whereas hADSCs were obtained by the 
enzymatic digestion of small human adipose tissue biopsies, as previously reported [37]. 
Both cell types were cultured in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum and 1% antibiotics/antimycotics (all from Merck) 
using standard cell culture conditions. 
To obtain recellularized limbi (RLs), DLs were first functionalized to increase the ad-
hesiveness of the decellularized scaffold and promote cell attachment by incubating the 
tissues in fetal bovine serum for 24 h with slight agitation. 
After functionalization, SIRC and hADSCs were trypsinized and carefully seeded on 
the surface of the DL (170,000 cells per cm2 of sample). To promote attachment, cells were 
resuspended in a minimal amount of medium (50 µL) and DLs were immobilized using 
agarose casts, as previously reported [38]. In order to induce epithelial differentiation of 
both cell types seeded on the RL, these tissues were cultured for 21 days in EM epithelial 
differentiation medium containing epithelial growth and differentiation factors, as previ-
ously described [39]. The EM medium consisted of a mixture of 150 mL of HAM-F12, 300 
mL of DMEM, 50 mL of fetal bovine serum, 1% antibiotics/antimycotics, 24 μg/mL of ad-
enine, 5 μg/mL of insulin, 1.3 ng/mL of triiodothyronine, 0.4 μg/mL of hydrocortisone, 
and 10 ng/mL of EGF (epidermal growth factor) (all of them, from Merck). 
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Preliminary transmittance analysis was carried out on RLs and controls using a 
SmartSpec 3000 spectrophotometer (Bio-Rad, Hercules, CA, USA). Each sample was ana-
lyzed at three wavelengths (400, 550, and 700 nm) using three replicates, and average val-
ues were obtained. 
2.4. Histological Analyses of DL and RL 
Control porcine and human native limbi, and DLs and RLs were fixed in 4% neutral 
buffered formaldehyde, dehydrated in increasing concentrations of ethanol, cleared in xy-
lene, and embedded in paraffin following routine protocols. In addition, 5 μm sections 
were obtained with a microtome, mounted on glass slides, dewaxed, and rehydrated with 
an ethanol series. 
To evaluate tissue morphology and structure, sections were stained with hematoxy-
lin-eosin (HE) (Panreac AppliChem, Barcelona, Spain). The structure and composition of 
the tissue extracellular matrix (ECM) were evaluated by identifying collagen fibers and 
proteoglycans using picrosirius red (PSR) and alcian blue (AB) histochemistry, as previ-
ously reported [36,40] (reagents from Panreac AppliChem). 
In order to identify specific components of the epithelial and basement membrane 
layers of RLs, controls and RLs were subjected to immunohistochemistry for p63, pancyt-
okeratin, crystallin Z (CRY-Z), laminin, and collagen IV. In brief, tissue sections were sub-
jected to antigen retrieval with pH 8 EDTA buffer (25 min at 95 °C) for p63, pancyt-
okeratin, and collagen IV or with pH 6 citrate buffer (25 min at 95 °C) for CRY-Z and 
laminin, and endogenous peroxidase was quenched with H2O2. Then, samples were pre-
incubated in a blocking solution containing horse serum and incubated with the following 
primary antibodies: anti-p63 (Master Diagnostica, Granada, Spain, prediluted), anti-pan-
cytokeratin (Master Diagnostica, prediluted), anti-CRY-Z (Abcam, Cambridge, UK, dilu-
tion 1:250), anti-laminin (Abcam, dilution 1:200), and anti-collagen IV (Master Diagnos-
tica, prediluted). After washing in PBS, tissues were incubated in secondary anti-mouse 
or anti-rabbit antibodies labeled with peroxidase (ImmPRESS reagent kit, Vector Labora-
tories; Burlingame, CA, USA, prediluted), washed in PBS, and incubated with diamino-
benzidine (DAB) (Vector Laboratories). In all cases, positive and negative control tissues 
were used, with negative controls corresponding to tissue sections subjected to the same 
protocol, except that the primary antibody was replaced by PBS to show the negative 
staining signal. Samples were then counterstained with Harry’s hematoxylin and co-
verslipped. 
2.5. Quantitative Analysis and Statistics 
Stained tissues were analyzed with an Eclipse 90i microscope (Nikon, Tokyo, Japan), 
and images were obtained using the same conditions (magnification, exposure time, con-
trast, etc.) for all samples stained with the same method to allow signal quantification. 
White light was used to analyze all samples, and polarized light microscopy was used to 
evaluate DL tissues stained with PSR. 
For PSR and AB histochemistry, the staining signal intensity and area fraction were 
quantified using the ImageJ software (National Institutes of Health, Bethesda, MD, USA), 
as previously reported [41]. Briefly, each histological image was analyzed by randomly 
selecting 10 points (for intensity) and 10 square areas (for area fraction), and both the sig-
nal intensity and the area occupied by the positive staining signal were calculated by the 
program, the background signal was subtracted, and averages were obtained for each 
type of sample. Results obtained for each sample were statistically compared with con-
trols using the Mann–Whitney tests with the RealStatistics software (Dr. Charles Zaiontz, 
Purdue University, West Lafayette, IN, USA). 
For the immunohistochemical analyses, results were semiquantitatively categorized 
as strongly positive signal (+++), positive signal (++), slightly positive signal (+), or nega-
tive signal (−), as previously reported [39]. 




3.1. Decellularization Efficiency of the Different Protocols Applied to the Porcine Limbus 
Analysis of the different decellularization protocols studied in this work revealed 
that the four protocols were able to efficiently decellularize the porcine corneal limbus. 
First, the efficiency of the decellularization process was evaluated by quantification of the 
residual DNA present in each type of sample. Results showed very high DNA content in 
control limbi (1742.58 ± 62.06 ng of DNA per mg of dry weight of tissue), whereas DL 
tissues subjected to decellularization had very low amounts of DNA, with all protocols 
showing less than 50 ng of DNA per mg of dry weight of tissue for both the FL and HL, 
thus fulfilling the requirements for decellularized tissues [35] (Figure 2). Differences with 
control FL and HL were statistically significant for all groups, but comparisons among the 
different types of decellularized tissues showed nonsignificant differences. 
 
Figure 2. Analysis of native porcine limbus (PCTR) and decellularized limbi using four different decellularization methods 
(P1 to P4). Each decellularization protocol was applied to the full-thickness limbus (FL) and the half-thickness limbus 
(HL). (A) Histological analysis using hematoxylin-eosin (HE) and DAPI. (B) Macroscopical images showing transparency 
levels of each DL on a black scale in millimeters. (C) Quantification of residual DNA (in ng of DNA per mg of dry weight 
of tissue) in controls and DL. Asterisks (*) represent statistically significant differences with both the FL and the HL con-
trols (p < 0.05). Nonsignificant differences were found among the different samples decellularized with P1, P2, P3, and P4. 
Scale bars: 50 μm. 
In order to evaluate the decellularization efficiency at the histological level (Figure 2), 
controls and DLs decellularized with each protocol were analyzed histologically using HE 
staining. As shown in Figure 1, native control limbi showed abundant cells at the epithelial 
and stromal layers of the tissue. However, the use of the four decellularization methods 
evaluated here resulted in a complete absence of detectable cells or cell debris in all DLs, 
for both the HE and DAPI staining methods, with no differences among samples, suggest-
ing that the four methods described here were fully efficient, although the typical pocket-
like structures found in the limbal area were not detected in DLs. 
Strikingly, we found that tissues decellularized with protocols P1, followed by P2, 
showed the most appropriate results in terms of transparency, especially when HLs were 
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used. In contrast, P3 and P4 resulted in an important alteration of corneal transparency 
(Figure 2). 
3.2. Histochemical Analysis of ECM Components Preservation in Decellularized Limbi 
The effects of each decellularization protocol on the structure and composition of the 
tissue ECM were evaluated using PSR and AB (Figures 3 and 4). As expected, we first 
found that native control limbi showed high PSR staining intensity and area fraction, sug-
gesting that a high number of collagen fibers were present in these tissues. Then, the anal-
ysis of DLs revealed a significant decrease in PSR intensity and area fraction in all samples 
(p < 0.05), except for HLs treated with the P1 protocol, which were comparable to controls 
for PSR staining intensity but were significantly lower than controls for the area fraction 
occupied by collagen fibers. 
 
Figure 3. Histochemical analysis of native porcine limbus (PCTR) and decellularized limbi using four different decellular-
ization methods (P1 to P4). Each decellularization protocol was applied to the full-thickness limbus (FL) and the half-
thickness limbus (HL). PSR: picrosirius red, PSR-POL: polarized-light picrosirius red, AB: alcian blue. Scale bars: 50 μm. 




Figure 4. Quantitative analysis of the picrosirius red (PSR) and alcian blue (AB) staining intensity and area fraction of 
decellularized limbi (DLs). Four decellularization protocols (P1 to P4) were applied to the full-thickness limbus (FL, blue 
bars) and the half-thickness limbus (HL, orange bars). Results are shown as average values normalized with respect to the 
native porcine limbus used as control (PCTR, green bars), which is considered as 100%, with error bars corresponding to 
standard deviations. Asterisks (*) represent statistically significant differences with the native porcine limbus used as con-
trol (p < 0.05). 
When polarized light was applied, we found that control corneas showed several 
types of properly oriented collagen fibers, with a mixture of red, orange, yellow, and green 
fibers. However, DLs tended to show a decrease in red and orange colors, especially in 
FLs and in HLs treated with protocol P3, suggesting a decrease in thick, mature fibers and 
an alteration of fiber alignment and orientation in these samples, as previously suggested 
[42]. 
Analysis of tissue proteoglycans using AB staining showed a significant decrease in 
the staining signal intensity in all samples, as compared to control native tissues (p < 0.05). 
However, when the area fraction corresponding to an AB-positive signal was analyzed, 
we found a significant decrease in FLs decellularized with P1 and in HLs treated with P2 
and P3, with the rest of samples being comparable to controls (p > 0.05). 
On the other hand, our preliminary analysis of the transparency of RLs showed that 
the average transmittance of these tissues ranged between 31.49 ± 9.14% of the transmit-
tance of HCTR found in RLs recellularized with hADSCs at 21 days of follow-up and 
102.44 ± 32.06% for limbi recellularized with SIRC at day 21 (Supplementary Table S1). 
3.3. Histological Analysis of Recellularized Limbi 
In the present work, we used DLs decellularized with protocol P1 applied to HLs, as 
this method allowed an efficient decellularization with the best results in terms of ECM 
preservation. When these tissues were recellularized with SIRC rabbit cornea epithelial 
cells, we found that cells tended to attach to the DL surface, forming a multilayered cell 
stratum, and tended to allocate in the pocket-like structures found in DLs (Figure 5). In 
addition, we found that the number of cells in each RL was high from the first analysis 
time at day 7, with very few changes at days 14 and 21. Cells showed several intercellular 
spaces at days 7 and 14, but not at day 21, when cells became more densely packed, alt-
hough the well-organized structure of the native cornea epithelium was not reached. 




Figure 5. Histological analysis of native controls and RLs recellularized with SIRC epithelial cells and hADSCs, at days 7 
(D7), 14 (D14), and 21 (D21) of follow-up using hematoxylin-eosin staining (HE). PCTR: Native porcine limbus used as 
control. HCTR: Native human limbus used as control. Pocket-like structures found in some of the images have been high-
lighted with arrows. Scale bars: 50 µm. 
Analysis of RLs containing hADSCs revealed that this type of cell was also able to 
attach to the tissue surface, but the number of cells was low at day 7, with few cell layers, 
and increased at day 14, with several cell layers. Interestingly, some of the cells became 
detached from the decellularized scaffold at day 21. As for the SIRC cells, abundant inter-
cellular spaces were found among hADSCs, and differed from the fine structure of the 
control tissues. Interestingly, the morphology of the hADSCs grown on the surface of the 
RL was elongated and spindle-shaped, whereas SIRC displayed a more rounded or po-
lygonal shape. 
3.4. Evaluation of Limbal Cell Markers in Recellularized Limbi 
In the first place, we analyzed the expression of the limbal stem cell marker p63 in 
controls and RLs (Figure 6). As expected, epithelial cells found in control limbi were 
strongly positive (+++), especially in the human limbus and in the basal layer of the por-
cine limbus. When the RLs were analyzed, we found that tissues recellularized with SIRC 
epithelial cells showed positive p63 expression (++) from day 7 to day 21, although at a 
lower level than controls. However, hADSCs showed negative p63 expression (−) at days 
7 and 14, and became positive (++) at day 21. Then, we assessed the expression of pancyt-
okeratin in each type of sample, and we found a strongly positive signal (+++) in human 
and porcine control limbi, and a positive expression in RLs containing SIRC cells at 7, 14, 
and 21 days of follow-up. In addition, the expression was negative (−) in RLs recellular-
ized with hADSCs kept ex vivo for 7 days, slightly positive at day 14, and became positive 
at day 21. Finally, our analysis of CRY-Z proteins revealed that human epithelial cells 
were strongly positive, although porcine cornea cells were negative for this marker. RLs 
containing SIRC were positive at the three time periods analyzed here, whereas RLs con-
taining hADSCs were negative at day 7, and slightly positive at days 14 and 21 of follow-
up ex vivo. 




Figure 6. Immunohistochemical analysis of the corneal epithelial cell markers p63, pancytokeratin, and crystallin Z (CRY-
Z) in RLs recellularized with SIRC cells and hADSCs at days 7 (D7), 14 (D14), and 21 (D21) of follow-up, porcine native 
limbus (PCTR), and human native limbus (HCTR). Insets correspond to higher-magnification images of cells showing the 
expression of each analyzed marker in the RL tissues. Scale bars: 50 µm for large images and 10 µm for the insets. 
3.5. Immunohistochemical Analysis of Basement Membrane Components in Recellularized Limbi 
Two of the main components of the basement membrane—laminin and collagen IV—
were analyzed by immunohistochemistry (Figure 7). In this regard, our results demon-
strated that the human native cornea expressed both proteins at the basement membrane 
of the epithelial cells, although the porcine cornea was negative for the two markers ana-
lyzed here. RLs containing SIRC cells were negative for laminin at all follow-up times, but 
were positive for collagen IV at days 14 and 21, being negative at day 7. However, RLs 
generated with hADSCs were negative for laminin and collagen IV at day 7 and became 
positive at days 14 and 21 for both markers. As expected, blood vessels found at the limbal 
tissue showed a positive staining signal for both laminin and collagen IV. 




Figure 7. Immunohistochemical analysis of the basement membrane markers laminin and collagen IV in RLs recellularized 
with SIRC cells and hADSCs at days 7 (D7), 14 (D14), and 21 (D21) of follow-up, porcine native limbus (PCTR), and human 
native limbus (HCTR). Illustrative areas of the basement membrane stained by the immunohistochemical procedure are 
highlighted with arrows. Scale bars: 50 µm. 
3.6. Histochemical Analysis of ECM Components in Recellularized Limbi 
Once recellularized, two major ECM components were analyzed in RL samples using 
PSR and AB (Figures 8 and 9). When the staining intensity was analyzed in samples 
stained with PSR, we found that the highest intensity corresponded to the native limbus 
controls. However, differences between controls and all types of RLs were nonsignificant 
at 7, 14, and 21 days (p > 0.05). However, we found that all RLs had lower PSR area frac-
tions than native controls did at the three times, with significant differences between the 
native limbi and all types of RLs. 




Figure 8. Histochemical analysis of native porcine limbus (PCTR), native human limbus (HCTR), and limbi recellularized 
with SIRC cells and hADSCs evaluated at days 7 (D7), 14 (D14), and 21 (D21) of follow-up. PSR: picrosirius red, AB: alcian 
blue. Scale bars: 50 μm. 
 
Figure 9. Quantitative analysis of the picrosirius red (PSR) and alcian blue (AB) staining intensity and area fraction of 
recellularized limbi (RLs). Results are shown as average values normalized with respect to the native limbi used as controls 
and shown in green (PCTR and HCTR), whose mean is considered as 100%, with error bars corresponding to standard 
deviations. Asterisks (*) represent statistically significant differences with both controls (PCTR and HCTR) (p < 0.05). 
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Analysis of ECM proteoglycans using AB histochemistry first revealed that the low-
est staining intensity corresponded to RLs containing hADSCs, with statistically signifi-
cant differences with native limbi for the three time periods analyzed here. In contrast, 
RLs generated with SIRC showed nonsignificant differences with controls at all times. Fi-
nally, we found that the area occupied by AB-positive staining was significantly lower in 
all types of RLs than in native controls at all times, with very few differences among RL 
samples and times. 
4. Discussion 
LSCD is a severe condition causing cornea opacification, conjunctival pannus, and 
blindness that can be secondary to chemical or thermal injuries, autoimmune diseases 
such as the Stevens–Johnson syndrome, mucous membrane pemphigoid, and hereditary 
diseases such as aniridia [43]. Current treatments are challenging, especially in cases with 
structural damage of the limbal area, which is not a candidate to cell therapy. In fact, 
maintenance of the crypt-like structures in which limbal stem cells reside is fundamental 
for these cells to survive and exert their function in the limbus, and structural alterations 
of this niche would lead to stem cell death [6]. 
In the present preliminary work, we generated several types of limbal substitutes 
that could be used in the future to replace the damaged limbus using both a corneal and 
an extracorneal cell source. Although the present report is a preliminary work, our results 
suggest that these bioartificial limbi display several similarities with the native limbus 
and, thus, could be potentially useful for the treatment of LSCD. 
In the first place, we evaluated several decellularization protocols applied to the na-
tive porcine limbus. Decellularization of native organs allows the obtaining of biological 
scaffolds composed of natural extracellular matrix (ECM) that can be used in regenerative 
medicine for tissue and organ replacement [35]. Compared with strategies based on scaf-
folds generated de novo such as fibrin, collagen, or agarose applied to cornea tissue engi-
neering [20,44], decellularization offers the possibility of obtaining a scaffold containing 
the Vogt palisades and crypt-like structures that are required for a proper limbal function 
[30]. In addition, previous works have demonstrated that the porcine limbus is structur-
ally similar to the human limbus [45]. 
Xenografts obtained by the decellularization of animal tissues can be used to repro-
duce human tissues and organs in the laboratory [46]. Compared with human tissues, 
xenografts are easily available and accessible, and can be obtained with very few ethical 
concerns. However, xenogeneic scaffolds may not be able to fully reproduce the structure 
and biochemical composition of the human tissues, and the expression of relevant anti-
genic components should be controlled before clinical use, as antigenicity could hinder 
the use of xenografts in regenerative medicine [47]. 
Numerous protocols have been described to date for the decellularization of different 
types of corneal xenografts [24]. However, very little information is available on decellu-
larization of the corneal limbus. In a preliminary work, we demonstrated previously that 
the porcine cornea can be decellularized in toto, including the limbus, using SDS deter-
gents [25]. Then, Huang et al. used a combined protocol using a mixture of salts, enzymes, 
and SDC and demonstrated that the porcine limbus could be decellularized and then re-
cellularized with cultured cells [48]. Very recently, Isidan et al. compared several methods 
applied to the whole porcine cornea and confirmed our preliminary results suggesting 
that SDS is the most effective decellularization agent for the whole cornea [28]. Based on 
the protocols described in all these previous reports, we selected four decellularization 
methods that were evaluated in the present work. In general, these methods were based 
on the use of the anionic detergents SDS and SDC, the nonionic surfactant Triton X-100, 
hypertonic NaCl, and trypsin digestion. 
Previous reports have suggested that decellularization of the whole cornea is chal-
lenging, and the efficiency of the decellularization protocols may be reduced when the 
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whole tissue is subjected to decellularization [28]. For this reason, we evaluated each de-
cellularization protocol on both the full-thickness limbus and the half-thickness limbus. 
Our results showed that all protocols were efficient on both the FL and the HL tissues, 
suggesting that the four protocols evaluated here were fully successful and are appropri-
ate for decellularization of the porcine limbus. However, protocol P1, which is based on 
the use of SDS detergent, was able to preserve the limbus ECM components and transpar-
ency more efficiently than other protocols could, especially when HLs were used. Alt-
hough differences were found with control native corneas, and the crypt-like structures 
were not detectable, probably due to tissue swelling, the collagen staining intensity and 
the proteoglycans area fraction were comparable with controls. For these reasons, and due 
to the fact that protocol P1 is one of the simplest decellularization protocols, we could 
recommend this protocol applied to HLs for porcine limbus decellularization. This is in 
agreement with previous results obtained by our group [25] and by other research groups 
[28]. However, additional analyses based on biochemical characterization of the decellu-
larized limbi should be performed to confirm these findings. In addition, our analysis of 
transparency was very preliminary, and in-depth analyses able to quantify the transmit-
tance of each DL with higher accuracy should be performed before and after glycerol 
treatment—to reduce swelling—as suggested [49]. 
An important issue related to decellularized tissues is biomechanical behavior. In 
general, it is well known that the biomechanical properties of tissues are important varia-
bles affecting tissue function and cell mechanotransduction [50]. However, the decellular-
ization process may significantly alter the structure of the tissue ECM and, thus, the bio-
mechanical properties of the decellularized scaffolds, which could alter the phenotype, 
proliferation capability, and differentiation potential of the cells cultured on this scaffold 
and modify cell behavior and tissue regeneration [51]. In fact, it has been demonstrated 
that decellularized corneal xenografts vary their biomechanical properties after decellu-
larization [52]. Therefore, a thorough analysis of the biomechanical properties of the DL 
generated in the present work is in need. 
Once decellularized, DLs should be repopulated with limbal stem cells for clinical 
use. Recellularization is also challenging, as not all cell types are able to grow and differ-
entiate on decellularized scaffolds. In the present work, we assessed two different types 
of cells for limbal recellularization: corneal epithelial cells and extracorneal cells with dif-
ferentiation potential (hADSCs). The use of alternative cell sources was previously sug-
gested by several researchers, who demonstrated that hADSCs have intrinsic potential to 
differentiate into several cornea cell phenotypes both ex vivo and in vivo [33,34,53]. First, 
different types of MSCs were differentiated into stromal keratocytes using conditioning 
media [34], suggesting that these cells could be used to support epithelial cell growth and 
differentiation. However, these cells were also demonstrated to have a differentiation po-
tential into cornea epithelial cells [33,34,53], which supports their use as alternative cell 
sources in cornea and limbus recellularization. In general, our results suggest that both 
types of cells were able to attach to this scaffold and showed several markers of cell dif-
ferentiation on the decellularized biomaterials. Interestingly, the morphology of each cell 
type was different, and hADSCs showed the typical structure of MSCs, and abundant 
intercellular spaces, at day 21. In general, these findings support the preferential use of 
SIRC over hADSCs, as SIRC cells are specifically committed to the limbal epithelial cell 
lineage, whereas hADSCs correspond to the undifferentiated phenotype that is typical of 
MSCs [54]. 
Although further research should determine the role of serum functionalization, the 
fact that cells were able to adhere to the decellularized scaffold could be related to the 
functionalization step applied to the DL. Previous reports have shown that most bio-
materials lack specific signals that are necessary for cell differentiation and function, and 
surface functionalization with serum proteins could contribute to mimic the in vivo sce-
nario and improve biomaterial functionality [55]. A possible concern of tissue functional-
ization with serum is the possibility of inducing cells to differentiate to noncorneal cell 
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lineages, such as the vascular phenotype. Future studies should determine if functionali-
zation is necessary and if alternative methods can be applied to DLs. 
To determine the feasibility of the scaffolds generated in this work to support limbal 
cell differentiation, we analyzed the expression of several markers of epithelial differenti-
ation. In general, our results obtained ex vivo suggest that none of the cell types were able 
to fully differentiate and mature on the scaffold, although partial signs of epithelial dif-
ferentiation were found. Concretely, SIRC cells were able to express the epithelial markers 
p63, pancytokeratin, and CRY-Z from the beginning, with no time-dependent differences. 
This is in agreement with the limbal epithelial stem cell nature of these cells and their 
intrinsic differentiation status [56]. However, hADSCs were initially negative for these 
three markers, as is the case of all types of human MSCs, but became positive or slightly 
positive for the three epithelial markers after 21 days of ex vivo differentiation induction 
using conditioning media. These results confirm the differentiation capability of hADSCs 
to the epithelial cell lineage under certain circumstances, as previously suggested [57,58]. 
Previous results published by our group demonstrated that these cells, which can be har-
vested autologously, can be differentiated ex vivo using conditioning media, although 
differentiation is not complete ex vivo and the in vivo environment is required for termi-
nal differentiation [58]. Interestingly, hADSCs were already used to efficiently recellular-
ize acellular scaffolds obtained from human corneas [59]. Future studies should be carried 
out on animal models to determine if these cells are able to fully differentiate into epithe-
lial cells upon in vivo induction, as demonstrated for the skin and oral mucosa [58,60]. 
Moreover, additional research is in need to fully characterize the cells grown on the de-
cellularized scaffolds to determine their exact phenotype. Specifically, immunostaining 
with the Ki-67 proliferation marker and labeling with BrdU should determine the prolif-
eration potential of these cells, whereas co-staining with limbal stem cell markers such as 
ABCG2, p63, and cytokeratin 15 should demonstrate their stem cell identity [61]. 
One of the main factors influencing epithelial cell attachment is the basement mem-
brane. Evaluation of this structure showed that two of its major components—laminin 
and collagen IV—were detectable in RLs from day 14 onward, suggesting that an incipient 
basement membrane was formed between the scaffold and the cells seeded on top. The 
fact that RLs containing SIRC were negative for laminin could be explained by the fact 
that the anti-laminin antibody used in this work was specific anti-human. 
In addition, the quantification of two key components of the limbus ECM revealed 
that RLs containing SIRC cells had adequate collagen fibers and proteoglycans—in terms 
of staining intensity—although the area fraction was not comparable to controls. The fact 
that SIRC cells are already committed to the limbal phenotype, whereas hADSCs are much 
more undifferentiated, may explain these findings. Despite its effect on collagen and pro-
teoglycans quantification likely being very low or negligible, it is also possible that ECM 
components found in RLs may be affected by tissue functionalization with serum. 
The present work has several limitations. The first one is the need of carrying out 
additional analyses, such as a biochemical analysis, to confirm the histological, histochem-
ical, and immunohistochemical results showed here, as well as extensive analysis of tissue 
transparency after decellularization and recellularization. Furthermore, DLs should be an-
alyzed using transmission electron microscopy techniques to determine if the limbal 
crypts are intact after the decellularization process. In addition, DLs should be recellular-
ized with human primary limbal stem cells, and the expression of relevant stem cell mark-
ers should be assessed in these cells such as specific limbal stem cell markers and cell 
proliferation markers, to determine the real potential of the decellularized scaffolds. Fu-
ture analyses should address all these issues. 
In summary, the preliminary results obtained in the present work demonstrated that 
the porcine cornea limbus can be efficiently decellularized using the protocols described 
here, and that recellularization with epithelial or mesenchymal cells allows the successful 
generation of RLs with potential clinical usefulness. Future experiments in animal models 
should determine the in vivo usefulness of these limbal substitutes. Among their possible 
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clinical applications, the limbal substitutes described here could be used as advanced ther-
apies and medicinal products in patients with severe structural alteration of the limbus 
and loss of the micro-niche of the limbal stem cells. 
5. Patents 
MCM and MA are coauthors of patent application number PCT/ES2020/070168, “decellularized 
limbus”. 
Supplementary Materials: The following are available online at www.mdpi.com/arti-
cle/10.3390/pharmaceutics13101718/s1, Table S1: Preliminary analysis of light transmittance at three 
different wavelengths (400, 550 and 700 nm) as determined by spectrophotometric analysis of hu-
man native limbus (HCTR) and RL decellularized with SIRC and hADSC cells at days 7, 14 and 21 
of follow-up. Values correspond to percentages of transmittance using the values obtained in HCTR 
as reference (100% transmittance). 
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